Literature DB >> 10465518

Tuftsin: on the 30-year anniversary of Victor Najjar's discovery.

I Z Siemion1, A Kluczyk.   

Abstract

After a short description of the results of Victor Najjar's research on tuftsin and of the discoveries done by other authors in the early stage of tuftsin investigation, the current state of work on tuftsin is presented, based mainly on the literature published in the years 1984-1997. The presentation follows this order: the occurrence of tuftsin and retro-tuftsin sequences in proteins, their synthesis and biology, the antigenic properties of tuftsin, its influence on phagocytic cells, and other biologic activities of tuftsin, including antimicrobial, antiviral, antitumor and central effects, and the search for tuftsin superactive analogs.

Mesh:

Substances:

Year:  1999        PMID: 10465518     DOI: 10.1016/s0196-9781(99)00019-4

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  21 in total

1.  A new property of the synthetic anxiolytic Selank and its derivatives.

Authors:  T S Pavlov; G E Samonina; L A Andreeva; N F Myasoedov; I P Ashmarin
Journal:  Dokl Biol Sci       Date:  2004 Jul-Aug

Review 2.  Tuftsin phosphorylcholine-a novel compound harnessing helminths to fight autoimmunity.

Authors:  Yahel Segal; Miri Blank; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

3.  Microglia/macrophages promote glioma progression.

Authors:  Haiyan Zhai; Frank L Heppner; Stella E Tsirka
Journal:  Glia       Date:  2010-12-29       Impact factor: 7.452

4.  Impaired tuftsin activity in cirrhosis: relationship with splenic function and clinical outcome.

Authors:  F Trevisani; E Castelli; F G Foschi; M Parazza; E Loggi; M Bertelli; C Melotti; M Domenicali; G Zoli; M Bernardi
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

5.  Novel therapeutic compound tuftsin-phosphorylcholine attenuates collagen-induced arthritis.

Authors:  T Bashi; O Shovman; M Fridkin; A Volkov; I Barshack; M Blank; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  2016-02-04       Impact factor: 4.330

6.  ITF1697, a stable Lys-Pro-containing peptide, inhibits weibel-palade body exocytosis induced by ischemia/reperfusion and pressure elevation.

Authors:  Silvia Bertuglia; Hideo Ichimura; Gianluca Fossati; Kaushik Parthasarathi; Flavio Leoni; Daniela Modena; Piero Cremonesi; Jahar Bhattacharya; Paolo Mascagni
Journal:  Mol Med       Date:  2007 Nov-Dec       Impact factor: 6.354

7.  Tuftsin-driven experimental autoimmune encephalomyelitis recovery requires neuropilin-1.

Authors:  Jillian C Nissen; Stella E Tsirka
Journal:  Glia       Date:  2016-02-16       Impact factor: 7.452

8.  Tuftsin signals through its receptor neuropilin-1 via the transforming growth factor beta pathway.

Authors:  Jillian C Nissen; David L Selwood; Stella E Tsirka
Journal:  J Neurochem       Date:  2013-09-18       Impact factor: 5.372

9.  Tuftsin-phosphorylcholine (TPC) equally effective to methylprednisolone in ameliorating lupus nephritis in a mice model.

Authors:  A Shemer; S Kivity; O Shovman; T Bashi; O Perry; A Watad; D Ben-Ami Shor; A Volkov; I Barshack; N L Bragazzi; A Krule; M Fridkin; H Amital; M Blank; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  2018-08       Impact factor: 4.330

10.  Tuftsin promotes an anti-inflammatory switch and attenuates symptoms in experimental autoimmune encephalomyelitis.

Authors:  Muzhou Wu; Jillian C Nissen; Emily I Chen; Stella E Tsirka
Journal:  PLoS One       Date:  2012-04-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.